Climb Bio Statistics

Total Valuation

Climb Bio has a market cap or net worth of $83.12 million. The enterprise value is -$114.25 million.

Market Cap	83.12M
Enterprise Value	-114.25M

Important Dates

The next estimated earnings date is Wednesday, August 13, 2025, before market open.

Earnings Date	Aug 13, 2025
Ex-Dividend Date	n/a

Share Statistics

Climb Bio has 67.58 million shares outstanding. The number of shares has increased by 113.10% in one year.

Current Share Class	67.58M
Shares Outstanding	67.58M
Shares Change (YoY)	+113.10%
Shares Change (QoQ)	+4.21%
Owned by Insiders (%)	0.55%
Owned by Institutions (%)	31.51%
Float	25.57M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.43
P/TBV Ratio	0.43
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 14.25, with a Debt / Equity ratio of 0.00.

Current Ratio	14.25
Quick Ratio	14.13
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -62.04% and return on invested capital (ROIC) is -19.56%.

Return on Equity (ROE)	-62.04%
Return on Assets (ROA)	-18.95%
Return on Invested Capital (ROIC)	-19.56%
Return on Capital Employed (ROCE)	-24.27%
Revenue Per Employee	n/a
Profits Per Employee	-$5.17M
Employee Count	18
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -83.94% in the last 52 weeks. The beta is -0.16, so Climb Bio's price volatility has been lower than the market average.

Beta (5Y)	-0.16
52-Week Price Change	-83.94%
50-Day Moving Average	1.25
200-Day Moving Average	2.75
Relative Strength Index (RSI)	47.64
Average Volume (20 Days)	201,728

Short Selling Information

The latest short interest is 2.19 million, so 3.25% of the outstanding shares have been sold short.

Short Interest	2.19M
Short Previous Month	2.19M
Short % of Shares Out	3.25%
Short % of Float	8.58%
Short Ratio (days to cover)	14.68

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-47.02M
Pretax Income	n/a
Net Income	-92.98M
EBITDA	n/a
EBIT	-47.02M
Earnings Per Share (EPS)	-$1.60

Full Income Statement

Balance Sheet

The company has $98.06 million in cash and $474,000 in debt, giving a net cash position of $197.37 million or $2.92 per share.

Cash & Cash Equivalents	98.06M
Total Debt	474,000
Net Cash	197.37M
Net Cash Per Share	$2.92
Equity (Book Value)	193.39M
Book Value Per Share	2.86
Working Capital	93.24M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-29.18M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Climb Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-113.10%
Shareholder Yield	-113.10%
Earnings Yield	-111.87%
FCF Yield	n/a

Analyst Forecast

The average price target for Climb Bio is $10.00, which is 713.01% higher than the current price. The consensus rating is "Buy".

Price Target	$10.00
Price Target Difference	713.01%
Analyst Consensus	Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1